Clarendon Hills, IL, United States of America

Vladimir Kalinichenko

This inventor holds 3 USPTO granted patents. Top assignee: University of Illinois. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Kalinichenko. Retrieved from https://idiyas.com/inventor/vladimir-kalinichenko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Vladimir Kalinichenko: Innovator in Tumor Cell Proliferation Inhibition

Introduction

Vladimir Kalinichenko is a notable inventor based in Clarendon Hills, IL (US). He has made significant contributions to the field of cancer research, particularly in the area of tumor cell proliferation. With a total of 3 patents to his name, his work focuses on innovative methods to combat tumor growth.

Latest Patents

Kalinichenko's latest patents revolve around methods of inhibiting tumor cell proliferation. His inventions provide techniques for inhibiting FoxM1B activity, expression, or nuclear localization in tumor cells. These methods not only aim to inhibit tumor cell proliferation but also focus on preventing tumor progression in animals. By targeting FoxM1B, his inventions offer promising avenues for cancer treatment.

Career Highlights

Vladimir Kalinichenko is affiliated with the University of Illinois, where he continues to advance his research in cancer biology. His work has garnered attention for its potential impact on therapeutic strategies against cancer.

Collaborations

Kalinichenko collaborates with esteemed colleagues such as Robert Costa and Pradip Raychaudhuri. Their combined expertise enhances the research efforts in the field of tumor biology.

Conclusion

Vladimir Kalinichenko stands out as an innovative inventor dedicated to developing methods for inhibiting tumor cell proliferation. His contributions to cancer research are significant and hold promise for future therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…